Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Carbon Monoxide Breathing on Blood Vessel Function
NCT03067701Phase 1Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Carbon monoxide in endothelial dysfunction, sponsored by Cedars-Sinai Medical Center. Primary endpoint: Flow Mediated Dilation. Started Jun 2017; status: completed.
02
Drugs
Carbon monoxide
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT03067701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067701.